Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
CALL
Teva Pharmaceuticals
TEVA
$44.4B
| $1.11M | ﹤0.01% |
61,400
+46,000
| +299% | +$805K |
|
1552
PUT
First Citizens BancShares
FCNCA
$24.4B
| $1.1M | ﹤0.01% |
+600
| New | +$1.14M |
|
1553
CALL
Chevron
CVX
$392B
| $1.1M | ﹤0.01% |
7,500
-34,600
| -82% | -$5.15M |
|
1554
Wingstop
WING
$3.1B
| $1.1M | ﹤0.01% |
2,652
-9,278
| -78% | -$3.6M |
|
1555
CALL
Crocs
CROX
$5.89B
| $1.1M | ﹤0.01% |
7,600
-7,100
| -48% | -$969K |
|
1556
Hyster-Yale Materials Handling
HY
$624M
| $1.1M | ﹤0.01% |
+17,253
| New | +$1.13M |
|
1557
loanDepot
LDI
$312M
| $1.1M | ﹤0.01% |
401,700
+362,001
| +912% | +$855K |
|
1558
CALL
Texas Roadhouse
TXRH
$13.3B
| $1.09M | ﹤0.01% |
6,200
+3,800
| +158% | +$641K |
|
1559
Mercer International
MERC
$28.6M
| $1.09M | ﹤0.01% |
161,592
+132,171
| +449% | +$914K |
|
1560
CALL
Elevance Health
ELV
$86.5B
| $1.09M | ﹤0.01% |
+2,100
| New | +$1.12M |
|
1561
PUT
FIVE9
FIVN
$2.41B
| $1.09M | ﹤0.01% |
+38,000
| New | +$1.37M |
|
1562
CALL
Marathon Petroleum
MPC
$99.7B
| $1.09M | ﹤0.01% |
6,700
-30,300
| -82% | -$5.12M |
|
1563
PUT
CAVA Group
CAVA
$8.09B
| $1.09M | ﹤0.01% |
8,800
-10,800
| -55% | -$1.1M |
|
1564
PUT
McKesson
MCK
$106B
| $1.09M | ﹤0.01% |
2,200
+1,800
| +450% | +$1M |
|
1565
PUT
Dow Inc
DOW
$21.8B
| $1.09M | ﹤0.01% |
19,900
+13,000
| +188% | +$686K |
|
1566
Treace Medical Concepts
TMCI
$313M
| $1.09M | ﹤0.01% |
+187,101
| New | +$1.2M |
|
1567
NewtekOne
NEWT
$360M
| $1.09M | ﹤0.01% |
+87,079
| New | +$1.1M |
|
1568
PUT
Qorvo
QRVO
$8.32B
| $1.08M | ﹤0.01% |
+10,500
| New | +$1.18M |
|
1569
CALL
CBRE Group
CBRE
$43.9B
| $1.08M | ﹤0.01% |
+8,700
| New | +$949K |
|
1570
Miller Industries
MLR
$649M
| $1.08M | ﹤0.01% |
17,737
+5,475
| +45% | +$329K |
|
1571
Vera Therapeutics
VERA
$2.54B
| $1.08M | ﹤0.01% |
+24,478
| New | +$929K |
|
|
CMRC
1572
Commerce.com Inc Series 1
CMRC
$193M
| $1.08M | ﹤0.01% |
184,913
-33,707
| -15% | -$222K |
|
1573
FormFactor
FORM
$8.42B
| $1.08M | ﹤0.01% |
+23,473
| New | +$1.17M |
|
1574
CALL
Leidos
LDOS
$16.9B
| $1.08M | ﹤0.01% |
6,600
-2,300
| -26% | -$348K |
|
1575
PUT
Parker-Hannifin
PH
$128B
| $1.07M | ﹤0.01% |
1,700
+1,200
| +240% | +$682K |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.